Pain and Inflammation Research
Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.
Pain and Inflammation Research Products Areas
Products for Pain and Inflammation Research - Page 23
- Cat.No. Product Name Information/Activity
-
BCC7864
Bepridil hydrochloride
Bepridil hydrochloride (CERM 1978) is a calcium channel blocker, with antianginal activity.
-
BCC1083
Cilnidipine
Cilnidipine(FRC8653) is a dual L- and N-type calcium channel blocker and displays antihypertensive, sympatholytic and neuroprotective activity.
-
BCC5700
ω-Conotoxin GVIA
106375-28-4
-
BCC5699
ω-Conotoxin MVIIC
147794-23-8
-
BCC4901
Diltiazem HCl
Diltiazem hydrochloride is a Ca2+ influx inhibitor (slow channel blocker or calcium antagonist).
-
BCC7767
Efonidipine hydrochloride monoethanolate
Efonidipine hydrochloride monoethanolate (NZ-105 hydrochloride monoethanolate) is a dual T-type and L-type calcium channel blocker (CCB).
-
BCC4402
Felodipine
Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker.
-
BCC4398
Flunarizine 2HCl
Flunarizine is a selective calcium entry blocker.
-
BCC8041
Huwentoxin XVI
Potent and reversible N-type Ca<sup>2+</sup> channel blocker
-
BCC3797
Isradipine (Dynacirc)
Isradipine(Dynacirc) is a calcium channel blocker with an IC50 of 34±8 μM.


